Stefano Cianci, Salvatore Giovanni Vitale, Roberto Tozzi, Pietro Cignini, Francesco Padula, Laura D'Emidio, Lucia Mangiafico, Claudio Giorlandino, Luigi Frigerio, Diego Rossetti, Salvatore Caruso
{"title":"输卵管原发性转移性绒毛膜癌与早期妊娠共存:1例报告。","authors":"Stefano Cianci, Salvatore Giovanni Vitale, Roberto Tozzi, Pietro Cignini, Francesco Padula, Laura D'Emidio, Lucia Mangiafico, Claudio Giorlandino, Luigi Frigerio, Diego Rossetti, Salvatore Caruso","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>fallopian tube choriocarcinoma coexistent with viable intrauterine pregnancy is an extremely rare condition.</p><p><strong>Case report: </strong>we present the first case reported in literature of tubal choriocarcinoma coexistent with viable intrauterine pregnancy detected at early gestational age (20 weeks) and successfully managed by seriate monitoring of maternal and fetal health status until 31 weeks, then treated by cesarean section followed by etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine (EMA-CO) chemotherapy protocol.</p><p><strong>Conclusions: </strong>the outcome was favorable for both the mother and her fetus.</p>","PeriodicalId":89592,"journal":{"name":"Journal of prenatal medicine","volume":"8 3-4","pages":"47-9"},"PeriodicalIF":0.0000,"publicationDate":"2014-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510563/pdf/47-49.pdf","citationCount":"0","resultStr":"{\"title\":\"Tubal primary metastatic choriocarcinoma coexistent with a viable early pregnancy: a case report.\",\"authors\":\"Stefano Cianci, Salvatore Giovanni Vitale, Roberto Tozzi, Pietro Cignini, Francesco Padula, Laura D'Emidio, Lucia Mangiafico, Claudio Giorlandino, Luigi Frigerio, Diego Rossetti, Salvatore Caruso\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>fallopian tube choriocarcinoma coexistent with viable intrauterine pregnancy is an extremely rare condition.</p><p><strong>Case report: </strong>we present the first case reported in literature of tubal choriocarcinoma coexistent with viable intrauterine pregnancy detected at early gestational age (20 weeks) and successfully managed by seriate monitoring of maternal and fetal health status until 31 weeks, then treated by cesarean section followed by etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine (EMA-CO) chemotherapy protocol.</p><p><strong>Conclusions: </strong>the outcome was favorable for both the mother and her fetus.</p>\",\"PeriodicalId\":89592,\"journal\":{\"name\":\"Journal of prenatal medicine\",\"volume\":\"8 3-4\",\"pages\":\"47-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2014-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510563/pdf/47-49.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of prenatal medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of prenatal medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Tubal primary metastatic choriocarcinoma coexistent with a viable early pregnancy: a case report.
Introduction: fallopian tube choriocarcinoma coexistent with viable intrauterine pregnancy is an extremely rare condition.
Case report: we present the first case reported in literature of tubal choriocarcinoma coexistent with viable intrauterine pregnancy detected at early gestational age (20 weeks) and successfully managed by seriate monitoring of maternal and fetal health status until 31 weeks, then treated by cesarean section followed by etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine (EMA-CO) chemotherapy protocol.
Conclusions: the outcome was favorable for both the mother and her fetus.